Edition:
United Kingdom

X T L Biopharmaceuticals Ltd (XTLB.OQ)

XTLB.OQ on NASDAQ Stock Exchange Capital Market

2.38USD
19 Jan 2018
Change (% chg)

$0.05 (+2.15%)
Prev Close
$2.33
Open
$2.36
Day's High
$2.38
Day's Low
$2.36
Volume
800
Avg. Vol
1,890
52-wk High
$4.69
52-wk Low
$1.93

Chart for

About

XTL Biopharmaceuticals Ltd. is a biopharmaceutical company. The Company focuses on the acquisition and development of pharmaceutical drugs for the treatment of medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action,... (more)
No analyst recommendations are available for .

Overall

Beta: -0.08
Market Cap(Mil.): $13.38
Shares Outstanding(Mil.): 5.14
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 85.70 16.58
EPS (TTM): -- -- --
ROI: -- 3.19 10.60
ROE: -- 4.52 14.19

Earnings vs. Estimates